AstraZeneca plc Vs British American Tobacco plc: Which Is The Better Dividend Stock?

If you’re looking for a great income, should you buy AstraZeneca plc (LON: AZN) or British American Tobacco plc (LON: BATS)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

With UK interest rates likely to remain low for some time, dividends are set to become an even more important feature of investing. And, while a great headline yield can be a useful starting point, there is much more to buying income stocks than the current yield.

For example, British American Tobacco (LSE: BATS) (NYSEMKT: BTI.US) currently yields a very appealing 3.9%, but this does not paint the full picture. That’s because British American Tobacco has an excellent track record of paying dividends, with it having increased them in each of the last five years.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

In fact, British American Tobacco’s dividends per share have risen at an annualised rate of 6.7% in the last four years, which provides an indication of the real terms increases that could be on offer moving forward.

It also shows that British American Tobacco can be considered a reliable income play, with its earnings being among the most stable in the FTSE 100. This compares favourably to AstraZeneca’s (LSE: AZN) (NYSE: AZN.US) sales, which are far less consistent than those of British American Tobacco, simply because the loss of key drugs can send its earnings (and dividends) downwards.

This has been the case in recent years, with AstraZeneca being forced to hold its dividend flat since 2011 as patent losses and generic competition have taken their toll on the company’s bottom line.

And, while in future AstraZeneca is expected to return to growth, this is not anticipated to occur until 2017 at the earliest, which means that significant growth in dividends could be severely lacking between now and then. As such, AstraZeneca’s current yield of 4.1% may not expand over the next couple of years unless its share price falls.

Of course, AstraZeneca’s dividend payout ratio is still below that of British American Tobacco even though the former’s earnings have slumped in recent years. While this would normally indicate that AstraZeneca has more scope to increase dividends than British American Tobacco, the stability of the latter means that, in actual fact, its 71% payout ratio (versus 66% for AstraZeneca) seems rather modest and could go much higher over the medium term, thereby providing an even brighter outlook for income-seeking investors.

So, while AstraZeneca’s headline yield of 4.1% is higher than British American Tobacco’s 3.9%, the added stability, consistency and track record of the latter make it a far more appealing income play. In fact, with the potential for additional growth in emerging markets and in the e-cigarette space, British American Tobacco could prove to be one of the most appealing stocks in the FTSE 100 at the present time, with it being all set to deliver a stunning total return in the long run.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Peter Stephens owns shares of AstraZeneca and British American Tobacco. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

How I’d invest a Stocks and Shares ISA with a 10-year time frame

Our writer explains how he focusses his Stocks and Shares investment choices by using a long-term perspective.

Read more »

UK money in a Jar on a background
Investing Articles

3 reasons to consider the 7% Legal & General dividend yield

The Legal & General dividend yield of 7% is one reason our writer would consider buying the shares for his…

Read more »

macro shot of computer monitor with FTSE 100 stock market data in trading application
Investing Articles

Should I buy this FTSE 250 defensive stock?

Jabran Khan is looking for defensive stock options for his holdings and delves deeper into this FTSE 250 food manufacturing…

Read more »

pink toy piggy money box on yellow background
Investing Articles

5 ‘no-brainer’ FTSE 250 shares to buy today

I'm seeing a lot of attractive dividend shares in the FTSE 250 right now. This approach gives me some very…

Read more »

Windmills for electric power production.
Investing Articles

The SSE share price slumps by 11%! Should I buy today?

The SSE share price tumbled today after talks of a windfall tax on electricity generators. Our writer considers if it’s…

Read more »

British Pennies on a Pound Note
Investing Articles

3 penny shares I own instead of Woodbois

Our writer prefers these three penny shares over hot stock Woodbois -- which is why he has bought them.

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Investing Articles

This FTSE 100 stock has tumbled in price. Here’s why I’d buy it now!

This FTSE 100 stock has tumbled to nearly half of its value since the start of 2022. This presents a…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

My top 5 big dividend stocks to buy before June!

With soaring inflation, I'm looking at dividend stocks to increase my returns in the near term and keep my portfolio…

Read more »